On the Record · Embecta
Embecta competitors, on the record
The companies Embecta itself names as competitors in its annual reports, 2023 to 2025, each with the sentence it appears in and the filing it came from.
Who Embecta names
| Company | Named in |
|---|---|
| MTD Group | 2025 |
| Novo Nordisk | 2025 |
| Terumo Medical Corporation | 2025 |
In its own words
MTD Group, Novo Nordisk, Terumo Medical Corporation
Word for word“Companies with whom we currently compete in the diabetes drug injection business include Novo Nordisk, MTD Group, and Terumo Medical Corporation.” 10-K for 2025
Read from Embecta’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2025-11-25. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.